The CTA New York oesophageal squamous cell carcinoma-1 (NY-ESO-1), also known as cancer-testis antigen 1B (CTAG1B), is immunogenic and reportedly induces specific B-cell and T-cell immunity in patients with NY-ESO-1-expressing cancers [79]. Here, CTAG1B is linked to cancer.